Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- artículo científico publicado en 1955 (es)
- articolo scientifico (pubblicato il 1955) (it)
- наукова стаття, опублікована в січні 1955 (uk)
- article scientifique publié en 1955 (fr)
- im Jahr 1955 veröffentlichter wissenschaftlicher Artikel (de)
- 1955 թվականի հունվարի 1-ին հրատարակված գիտական հոդված (hy)
- artículu científicu espublizáu en xineru de 1955 (ast)
- artikull shkencor i botuar më 01 janar 1955 (sq)
- scientific article published on 01 January 1955 (en)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - J J BUNIM
- A J BOLLET
- M M PECHET
|
rdfs:label
| - Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (en)
- Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (nl)
- Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (sq)
|
skos:prefLabel
| - Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (en)
- Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (nl)
- Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (sq)
|
name
| - Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (en)
- Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (nl)
- Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (sq)
|
title
| |
title
| - Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1001/JAMA.1955.02950210007003
|
is about
of | |
is cites work
of | - The transplacental passage of prednisone and prednisolone in pregnancy near term
- Metabolic studies with a new series of 1, 4-diene steroids. I. Effects in addisonian subjects of prednisone, prednisolone, and the 1, 2-dehydro analogues of corticosterone, desoxycorticosterone, 17-hydroxy-11-desoxycorticosterone, and 9 alpha-fluoro
- Metabolic effects of metacortandracin (prednisone) and metacortandralone (prednisone): comparison with ACTH, cortisone, hydrocortisone and 9-alphafluorohydrocortisone
- Clinical and metabolic effects of prednisone
- Clinical uses and hazards of adrenal steroids and their analogues in the management of rheumatic diseases
- Metabolic and antirheumatic activities of 6-methylprednisolone (medrol).
- Triamcinolone therapy in rheumatoid arthritis
- Metabolic studies with a new series of 1, 4-diene steroids. II. Effects in normal subjects of prednisone, prednisolone, and 9 alpha-fluoroprednisolone
- Treatment of nephrosis with prednisolone
- Prednisone in rheumatoid arthritis: metabolic and clinical effects
- The metabolic effects of the acetic and propionic acid analogs of thyroxine and triiodothyronine
- Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding
- Conversion of cortisone to cortisol and prednisone to prednisolone
- [High dosages of prednisone and prednisolone in treatment of blood diseases]
- Corticosteroid-induced adverse events in adults: frequency, screening and prevention
- Clinical comparison of the newer anti-inflammatory corticosteroids
- Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.
- The immunologic effects, kinetics, and use of glucocorticosteroids
- On the problem of femoral neck fractures in chronic polyarthritis treated with steroids
- THE EFFECTS OF STRUCTURAL ALTERATION ON THE ANTI-INFLAMMATORY PROPERTIES OF HYDROCORTISONE
- Present therapeutic status of cortisone and its derivatives, with special reference to rheumatic diseases.
- Prednisone and prednisolone in rheumatoid arthritis; an evaluation of their therapeutic efficiency
- The metabolism of cardiac lactones by microorganisms
- Effect of surgical operation on the plasma clearance of infused prednisolone
- Views on glucocorticoid therapy in rheumatology: the age of convergence
- The activity of different steroids in producing thymic involution
- The clinical evaluation of meticorten in rheumatoid arthritis and allied conditions
- Long-term use of prednisone (meticorten) in generalized cases of lupus erythematosus, scleroderma and neurodermatitis disseminata
- Emergency aspects of corticosteroid therapy
- Triamcinolone in the treatment of rheumatoid arthritis.
- Prednisone and prednisolone in the treatment of rheumatoid arthritis
- Fatal duodenal perforation during prednisone therapy
- Perforated duodenal ulcer complicating prednisolone therapy
- Hormone replacement (substitution) therapy in the surgery of endocrine disorders
- 16a-Methyl corticosteroids; a new series of anti-inflammatory compounds; clinical appraisal of their antirheumatic potencies.
- Two years' experience of prednisone in rheumatoid arthritis
- [A new synthetic glucocorticoid; clinical orientation]
- Side effects of systemic adrenal steroid therapy
- Amenorrhea: diagnosis and therapy
- Pemphigus vulgaris treated with metacortandracin; case report
- The structure and biologic activity of the corticosteroid hormones and ACTH
- Elimination profiles of prednisone and prednisolone after different administration routes: evaluation of the reporting level and washout periods to ensure safe therapeutic administrations
- Metacortandracin and 9-alpha-fluoro hydrocortisone acetate in rheumatic diseases
- Clinical evaluation of prednisone in collagen diseases
- Dexamethasone
- Potassium supplements in patients treated with corticosteroids
- Hydrocortisone versus prednisolone in rheumatoid arthritis
- HORMONE therapy of rheumatoid arthritis
- Prednisone and prednisolone in the treatment of rheumatoid arthritis
- The use of triamcinolone (aristocort) in selected dermatoses.
- Effect of substituting groups on the reduction of the Δ4 bond of steroids
|